A Phase 3b, multicenter, randomized, double blind, Placebo-controlled, parallel-group trial with an open label extension phase to evaluate efficacy and safety of avatrombopag for the treatmnet of trombocytopenia in pediatric subject with immune trombocytopenia for > 6 months
Karakaş Z. (Executive), Tanyıldız H. G.
Other International Funding Programs, 2021 - 2023
-
Project Type:
Other International Funding Programs
-
Begin Date:
July 2021
-
End Date:
August 2023